A
Exchange
—
Entity type
operating
Fiscal year end
Dec 31
Headquarters
DE
Recent Filings
- SC 13G/A230.8 KBAstex Pharmaceuticals, IncFeb 14, 11:34 AM ET·0001193125-14-053526
- 414.4 KBAstex Pharmaceuticals, IncOct 16, 7:35 PM ET·0001179110-13-015577
- 413.3 KBAstex Pharmaceuticals, IncOct 16, 7:34 PM ET·0001179110-13-015576
- 410.7 KBAstex Pharmaceuticals, IncOct 16, 7:34 PM ET·0001179110-13-015574
- 444.3 KBAstex Pharmaceuticals, IncOct 16, 7:33 PM ET·0001179110-13-015573
- 431.2 KBAstex Pharmaceuticals, IncOct 16, 7:33 PM ET·0001179110-13-015572
- 410.8 KBAstex Pharmaceuticals, IncOct 16, 7:33 PM ET·0001179110-13-015571
- 427.2 KBAstex Pharmaceuticals, IncOct 16, 7:32 PM ET·0001179110-13-015570
- 427.3 KBAstex Pharmaceuticals, IncOct 16, 7:32 PM ET·0001179110-13-015569
- 426.9 KBAstex Pharmaceuticals, IncOct 16, 7:31 PM ET·0001179110-13-015568
Insiders
10- AZAB MOHAMMADChief Medical Officer
- Bearss DavidChief Scientific Officer
- Berk GregoryChief Medical Officer
- BIOTECHNOLOGY VALUE FUND L PDirect Beneficial Owner
- Buckland MartinChief Business Officer
- BVF INC/IL10% Owner
- BVF PARTNERS L P/IL10% Owner
- CASAMENTO CHARLES JDirector
- Fellner PeterDirector
- GIRARDI THOMAS VDirector
Tickers
No tickers on record
Addresses
business
4140 DUBLIN BLVD SUITE 200
DUBLIN, CA, 94568
mailing
4140 DUBLIN BLVD STE 200
DUBLIN, CA, 94568
Former Names
- SUPERGEN INC2011-08-09